Companiesandmarkets.com

Intravenous immunoglobulin market used the highest throughout the US and Europe

Press Release   •   Oct 26, 2012 11:23 BST

The intravenous immunoglobulin market has been forecast to exceed US$9.0 billion by 2018, with the sector being boosted by the increasing acceptance among consumers, whose confidence regarding the safety of these products is on the upswing.

Factors such as rise in bleeding disorders, ballooning global population, and an increase in global per capita GDP are spurring growth of the immunoglobulin market. Other stimulants to the global Intravenous Immunoglobulin market include greater awareness regarding medical benefits, off-label use, and increased identification of patients afflicted with primary immune deficiency.

Intravenous immunoglobulin is a blood product administered intravenously. It contains the pooled, polyvalent, IgG (immunoglobulin (antibody) G) extracted from the plasma of over one thousand blood donors. IVIG's effects last between 2 weeks and 3 months. It is mainly used as treatment in three major categories:

1. Immune deficiencies such as X-linked agammaglobulinemia, hypogammaglobulinemia (primary immune deficiencies), and acquired compromised immunity conditions (secondary immune deficiencies) featuring low antibody levels.
2. Autoimmune diseases, e.g. Immune thrombocytopenia ITP, and Inflammatory diseases, e.g. Kawasaki disease.
3. Acute infections.

Intravenous immunoglobulin usage is highest in the US, followed by Sweden, Austria, and France. Testing of IVIG as therapy in Alzheimer's disease is underway, and approval for this treatment is expected to create a surge in demand for intravenous immunoglobulin.

Organisationally, the Intravenous Immunoglobulin market continues to witness structural reformations such as industry mergers, vertical integrations, and increased manufacturing competencies in a bid for stable growth and market proliferation.

For more information on the intravenous immunoglobulin market, see the latest research: Intravenous Immunoglobulin Market

Follow us on Twitter @CandMResearch

Companiesandmarkets.com issues news updates and report summaries covering all major industries and sectors. The service provides additional client monitoring and timely alerts to breaking industry and sector news leading the day's business headlines. News articles, written by our staff, contain additional analyst insight, providing value added insight for our readers. News updates and real-time alerts on newly-released market reports are also available from our Facebook page, Twitter feed @CandMResearch and RSS links. We also welcome inquiries from business journalists and the news media.